Comparison of diagnostic performance between induced sputum or endotracheal aspiration and bronchoalveolar lavage fluid in Pneumocystis jirovecii pneumonia

Status

Unknown

Phases

Phase 3

Study type

Interventional

Source

TCTR

Registry ID

TCTR20221027003

Enrollment

120

Registered

2022-10-27

Start date

2023-01-01

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Adult Immunocompromised host PCP immunocompromised host Qauntitative PCR

Interventions

All patients will be sends specimen from induced sputum or tracheal suction and bronchoalveolar lavage fluid for Quantitative PCR

Experimental Procedure/Surgery

quantitative PCR

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Inpatient Immunocompromised host or received immunosuppressive agent Suspected pneumonia Performed bronchoalveolar lavage

Exclusion criteria

Exclusion criteria: Not performed bronchoalveolar lavage Active Covid 19 infection

Design outcomes

Primary

Measure	Time frame
Sensitivity and Specificity 18month qPCR	—

Secondary

Measure	Time frame
agreement of diagnosis 18 month qPCR	—

Countries

Thailand

Contacts

Public ContactPakpoom Phoompoung

Faculty of Medicine, Siriraj Hospital, Mahidol University

pakpoom.pho@mahidol.ac.th0896883653

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026